Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Letter from the Editor
How many of our patients change their oil as soon as the change oil light comes on, or rotate and balance their tires when the maintenance schedule calls for it? Based on a few emails I sent out, almost everyone does. They feel that that preventative care can save them 1000’s of dollars later on. It would be nice if our patients felt the same way about their bodies and their rising weight and development of diabetes. I think part of the problem is that patients may think they know what preventative maintenance for diabetes is, but really they don’t.
This week our USF PharmD Candidate, Jasmine Dumontier-Hiott, has a great review of a large study on the benefits of prevention interventions and how you can help your patients, in our Laterpay feature.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
Newsflash: USPSTF Lowers Recommended Screening Age for Type 2 Diabetes
The U.S. Preventive Services Task Force (USPSTF) has lowered the recommended starting age of screening for type 2 diabetes from age 40 to 35 and recommends screening for prediabetes and type 2 diabetes in adults with overweight or obesity ages 35 to 70. The USPSTF also recommends that clinicians should offer or refer patients with prediabetes to effective preventive interventions.
TOP STORIES — Diabetes News and Research
American Diabetes Association mini-symposium presented by Mike Sampson, MD.
Diabetes is the leading cause of chronic kidney disease due to microvascular damage to the renal blood vessels.
A recent longitudinal study examines diabetes type 1 and brain cognitive differences in children.
Did You Know? New Glucagon Delivery System Can Prevent Hypo's Day & Night
Researchers have created novel hydrogels that can release glucagon into the body only when needed, preventing a sudden drop in blood glucose. The hydrogels described could be used to prevent overnight hypoglycemic episodes, especially in children, the researchers said.
The conventional use of glucagon has been reconsidered in a new investigation that has explored using it as a preventative, rather than an emergency, measure. Currently, glucagon injections control rising blood sugar levels for a sufficient time before medical care is available. Biomolecular engineers believe it could be more beneficial to dispense glucagon as a preventative measure instead of in emergencies. They have produced hydrogels that stay together when close to a glucose molecule but gradually weaken when levels decrease, freeing glucagon into the body and increasing glucose levels. In addition, they have engineered a control cycle using a hydrogel that breaks down when glucose levels drop to release glucagon as needed.
Acute hypoglycemic attacks are widespread in children with type 1 diabetes, leaving parents feeling anxious about it occurring during the night. Rapid declines in blood sugars are not visible during the night, therefore putting children with the condition at risk of dying or entering a coma. “A parent can check their child’s glucose levels right before they go to bed and everything looks fine, then around 2 am their blood sugar is dangerously low and near-comatose level.” Journal of the American Chemical Society
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:
Ashley Ball, PharmD Candidate, LECOM-School of Pharmacy
Jasmine Dumontier-Hiott, PharmD Candidate 2022, University of South Florida Taneja College of Pharmacy
Kornelia Ilias, Creighton University | School of Pharmacy and Health Professions Doctor of Pharmacy Candidate Class of 2022
Alan Martinez, PharmD Candidate, University of South Florida Taneja College of Pharmacy
Marianis Barreto Quintana, PharmD. Candidate, LECOM School of Pharmacy
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com